Search Results - "Schiffmann, Insa"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool by Kosch, Ricardo, Schiffmann, Insa, Daumer, Martin, Lederer, Christian, Scalfari, Antonio, Galea, Ian, Scheiderbauer, Jutta, Rahn, Anne, Heesen, Christoph

    Published in Multiple sclerosis (01-08-2021)
    “…Background: Prognostic counselling is a sensitive issue in medicine and especially so in MS due to the highly heterogeneous disease course. However, people…”
    Get full text
    Journal Article
  2. 2

    The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells by Greve, Gabriele, Schiffmann, Insa, Pfeifer, Dietmar, Pantic, Milena, Schüler, Julia, Lübbert, Michael

    Published in BMC cancer (16-12-2015)
    “…The receptor tyrosine kinase (RTK) EGFR is overexpressed and mutated in NSCLC. These mutations can be targeted by RTK inhibitors (TKIs) such as erlotinib…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy by Giovannetti, Ambra Mara, Pietrolongo, Erika, Borreani, Claudia, Giordano, Andrea, Schiffmann, Insa, Barabasch, Anna, Heesen, Christoph, Solari, Alessandra

    Published in PloS one (13-02-2020)
    “…Conversion to secondary progressive multiple sclerosis (SPMS) is associated with a relatively poor prognosis, and SPMS is responsible for the majority of the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives by Schiffmann, Insa, Greve, Gabriele, Jung, Manfred, Lübbert, Michael

    Published in Epigenetics (01-12-2016)
    “…Non-small cell lung cancer (NSCLC) still constitutes the most common cancer-related cause of death worldwide. All efforts to introduce suitable treatment…”
    Get full text
    Journal Article
  11. 11

    Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid by Greve, Gabriele, Schiffmann, Insa, Lübbert, Michael

    “…Purpose The retinoic acid signaling pathway, crucial for differentiation, is silenced by epigenetic mechanisms in many cancers. Epigenetically active,…”
    Get full text
    Journal Article
  12. 12

    Emotions towards magnetic resonance imaging in people with multiple sclerosis by Engels, Katharina, Schiffmann, Insa, Weierstall, Roland, Rahn, Anne Christin, Daubmann, Anne, Pust, Gesa, Chard, Declan, Lukas, Carsten, Scheiderbauer, Jutta, Stellmann, Jan‐Patrick, Heesen, Christoph

    Published in Acta neurologica Scandinavica (01-06-2019)
    “…Objectives People with multiple sclerosis (pwMS) often have magnetic resonance imaging (MRI) examinations. While MRI can help guide MS management, it may be a…”
    Get full text
    Journal Article
  13. 13

    Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases by Schubert, Charlotte, Schiffmann, Insa, Farschtschi, Said C, Emile, Jean-François, Friese, Manuel A

    “…Histiocytic disorders are pathologic expansions of myeloid cells in multiple organs, including the CNS. They share activation of the MAP kinase pathway due to…”
    Get full text
    Journal Article
  14. 14

    Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review by Rahn, Anne C., Köpke, Sascha, Stellmann, Jan‐Patrick, Schiffmann, Insa, Lukas, Carsten, Chard, Declan, Heesen, Christoph

    Published in Acta neurologica Scandinavica (01-01-2019)
    “…Magnetic resonance imaging (MRI) is the key prognostic tool in people with a clinically isolated syndrome (CIS). There is increasing interest in treating…”
    Get full text
    Journal Article
  15. 15